Pfizer’s $2.3 Billion Settlement Leaves Victims in the lurch
Pfizer, the world’s largest drug manufacturer has the dubious distinction of being a corporate "repeat offender…"
Pfizer, the world’s largest drug manufacturer has the dubious distinction of being a corporate "repeat offender…"
Ghostwritten journal reports masquerading as scientifically validated reports are a menace to public health.
Two high ranking FDA officials’ conflicts of interest have led one to resign, the other is under investigation by the Inspector General of the Department of Health and Human Services:
At the July 30, 2009 FDA advisory committee hearing, the only formal presentations at the meeting were a summary of the safety and efficacy data by the sponsor.
History is about to repeat itself: This is a follow up to a July 26, 2009 I nfomail.
“I was trained from day one to market the drug illegally…My job was to promote Neurontin and motivate doctors to experiment on patients. After being hired as a medical liaison, I was selling drugs. The uses promoted were from the “snake-oil list” of 13 medical conditions."
…an aggressive campaign to vaccinate against the swine flu–EVEN BEFORE THE VACCINE’S SAFETY HAS BEEN TESTED, or the safety of the vaccine adjuvants have been tested.
Unless the overall treatment and services provided to schizophrenia patients in Finland is unique and especially protective—which the authors do not suggest—their claimed findings of lowered mortality rates for antipsychotic drug users are belied by a consistent body of evidence.
But FDA says keep taking the "medicines."
Among the most damaging scientific evidence against the use of antipsychotic drugs is empirical evidence that they cause brain damage.
The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent.
"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale.